...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
【24h】

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

机译:垂体生长激素释放激素受体及其剪接变异体在正常和赘生性人类组织中的表达

获取原文
获取原文并翻译 | 示例
           

摘要

Various attempts to detect human pituitary growth hormone-releasing hormone receptor (pGHRH-R) in neoplastic extrapituitary tissues have thus far failed. Recently, four splice variants (SVs) of GHRH-R have been described, of which SV1 has the highest structural homology to pGHRH-R and likely plays a role in tumor growth. The aim of this study was to reinvestigate whether human tumors and normal human extrapituitary tissues express the pGHRH-R and to corroborate our previous findings on its SVs. Thus, we developed a real-time PCR method for the detection of the mRNA for the pGHRH-R, its SVs, and the GHRH peptide. Using real-time PCR, Western blotting, and radioligand-binding assays, we detected the mRNA for pGHRH-R and pGHRH-R protein in various human cancer cell lines grown in nude mice and in surgical specimens of human lung cancers. The expression of mRNA for SVs of pGHRH-R and GHRH was likewise found in xenografts of human non-Hodgkin's lymphomas, pancreatic cancer, glioblastoma, small-cell lung carcinomas, and in human nonmalignant prostate, liver, lung, kidney, and pituitary. Western blots showed that these normal and malignant human tissues contain SV1 protein and immunoreactive GHRH. Our results demonstrate that some normal human tissues and tumors express mRNA and protein for the pGHRH-R and its splice variants. These findings confirm and extend the concept that GHRH and its receptors play an important role in the pathophysiology of human cancers.
机译:迄今为止,在肿瘤性垂体外组织中检测人垂体生长激素释放激素受体(pGHRH-R)的各种尝试均告失败。最近,已经描述了GHRH-R的四个剪接变体(SV),其中SV1与pGHRH-R具有最高的结构同源性,并且可能在肿瘤生长中起作用。这项研究的目的是重新研究人类肿瘤和正常人脑垂体组织是否表达pGHRH-R,并证实我们先前关于其SV的发现。因此,我们开发了一种实时PCR方法,用于检测pGHRH-R,其SV和GHRH肽的mRNA。使用实时PCR,蛋白质印迹和放射性配体结合测定,我们在裸鼠和人类肺癌手术标本中生长的各种人类癌细胞系中检测到了pGHRH-R和pGHRH-R蛋白的mRNA。同样在人类非霍奇金淋巴瘤,胰腺癌,成胶质细胞瘤,小细胞肺癌以及人类非恶性前列腺,肝,肺,肾和垂体的异种移植物中也发现了pGHRH-R和GHRH SV的mRNA表达。 Western印迹表明,这些正常和恶性的人体组织均含有SV1蛋白和免疫反应性GHRH。我们的结果表明,某些正常的人类组织和肿瘤表达pGHRH-R及其剪接变体的mRNA和蛋白质。这些发现证实并扩展了GHRH及其受体在人类癌症的病理生理中起重要作用的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号